About Sanofi
We are a pharmaceutical company of French origin, present in the Southern Cone (Argentina, Chile, Uruguay and Paraguay) for more than 40 years. We have more than a century of history and experience in global healthcare: we started as a small French company and after mergers and acquisitions we became a world leader in the healthcare industry. We are one of the leading healthcare companies in Europe and the world, with a presence in more than 100 countries and more than 100,000 employees.
We always seek to challenge ourselves, so we undertook a process of modernization not only in relation to therapies but also as part of our growth as an organization. That is why we renewed our identity, to reflect everything we are and do at Sanofi.
In Argentina, we also have an Industrial Plant for the production of vaccines in Parque Industrial Pilar, GBA; a Quality Laboratory in Parque Industrial La Cantábrica, Morón, GBA. and a Quality Laboratory exclusively for Consumer Health products (over-the-counter) in Tapiales, La Matanza, Pcia. de Buenos Aires.
Our ambition is to improve the lives of our patients, environment, communities and our employees. We pursue the miracles of science to improve people's lives.
Parental License
We are the first health care company to offer up to 6 months paid parental leave for all our employees.
Diversity and Inclusion
We have 700 employees in the Southern Cone, 56% of whom are women, demonstrating our commitment to gender balance.
Research and Development
We are a company passionate about research and the constant search for new molecules to develop drugs, treatments and vaccines that improve people's lives. Through clinical studies, we research and develop innovative, safe and effective solutions for thousands of people around the world.
700
people work in 4 countries in the Southern Cone: Argentina, Chile, Uruguay and Paraguay.
12million Euros
annual external investment in research
1
Industrial Plant located in the Pilar Industrial Park. This site produces the hepatitis B antigen that is exported to Sanofi's central laboratories in France for its incorporation in the hexavalent vaccine for pediatric use.